Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Retatrutide has an estimated plasma half-life of approximately 6 days, supporting once-weekly subcutaneous dosing
(1996) reported the analog was 1.5-2x more potent than equimolar IGF-1 in catabolic rat models, and broader pharmacology literature places it at roughly 3x potency overall
CJC-1295 with DAC (Drug Affinity Complex): Modified with a lysine linker enabling albumin binding, this version has an extended half-life of approximately 6-8 days
Many insurance plans dont cover weight-loss medications like Saxenda and Wegovy, with less than one-fifth of large companies health care plans covering GLP-1s for weight loss
High-dose cisplatin induces significant renal and hepatic injury
Retatrutide is in Phase 3 clinical trials traditionally one of the final steps before the FDA reviews and potentially approves a drug
US$ 23.77
US$ 24.43
US$ 28.16
US$ 24.88
US$ 29.58
US$ 21.49
US$ 27.60
US$ 23.10
